Synthetic Lethality Screen Identifies RPS6KA2 as Modifier of Epidermal Growth Factor Receptor Activity in Pancreatic Cancer

Pancreatic cancer is characterized by a high degree of resistance to chemotherapy. Epidermal growth factor receptor (EGFR) inhibition using the small-molecule inhibitor erlotinib was shown to provide a small survival benefit in a subgroup of patients. To identify kinases whose inhibition acts synerg...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Milosevic, Nada, Kühnemuth, Benjamin, Mühlberg, Leonie, Ripka, Stefanie, Griesmann, Heidi, Lölkes, Carolin, Buchholz, Malte, Aust, Daniela, Pilarsky, Christian, Krug, Sebastian, Gress, Thomas, Michl, Patrick
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press Inc. 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884526/
https://ncbi.nlm.nih.gov/pubmed/24403857
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia